Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica.
about
Food-borne trematodiasesCurrent status of vaccines for schistosomiasisStructural and Functional Relationships in the Virulence-associated Cathepsin L Proteases of the Parasitic Liver Fluke, Fasciola hepaticaTransmission dynamics of Schistosoma japonicum in the lakes and marshlands of ChinaEfficacy and safety of artemether in the treatment of chronic fascioliasis in Egypt: exploratory phase-2 trialsIn vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopesOpisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and LaosZoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases.Induction of immunity in sheep to Fasciola hepatica with mimotopes of cathepsin L selected from a phage display library.The importance of pH in regulating the function of the Fasciola hepatica cathepsin L1 cysteine proteaseCathepsin F cysteine protease of the human liver fluke, Opisthorchis viverrini.A cluster-randomised intervention trial against Schistosoma japonicum in the Peoples' Republic of China: bovine and human transmission.Proteolytic activity in Fasciola hepatica is reduced by the administration of cathepsin L mimotopes.Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses.Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam.Fasciola hepatica and Schistosoma mansoni: identification of common proteins by comparative proteomic analysis.In vivo and in vitro sensitivity of Fasciola hepatica to triclabendazole combined with artesunate, artemether, or OZ78Fasciola hepatica fatty acid binding protein induces the alternative activation of human macrophages.Fasciola hepatica fatty acid binding protein inhibits TLR4 activation and suppresses the inflammatory cytokines induced by lipopolysaccharide in vitro and in vivo.Fasciola hepatica Surface Coat Glycoproteins Contain Mannosylated and Phosphorylated N-glycans and Exhibit Immune Modulatory Properties Independent of the Mannose ReceptorTranscriptome profiling of gene expression during immunisation trial against Fasciola hepatica: identification of genes and pathways involved in conferring immunoprotection in a murine modelImmune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae.A deep exploration of the transcriptome and "excretory/secretory" proteome of adult Fascioloides magna.In vitro tegumental alterations on adult Fasciola gigantica caused by mefloquine.In vitro manipulation of gene expression in larval Schistosoma: a model for postgenomic approaches in Trematoda.DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo.Immunization and challenge shown by hamsters infected with Opisthorchis viverrini following exposure to gamma-irradiated metacercariae of this carcinogenic liver fluke.Ov-APR-1, an aspartic protease from the carcinogenic liver fluke, Opisthorchis viverrini: functional expression, immunolocalization and subsite specificityAn AC-5 cathepsin B-like protease purified from Haemonchus contortus excretory secretory products shows protective antigen potential for lambsAn integrated transcriptomics and proteomics analysis of the secretome of the helminth pathogen Fasciola hepatica: proteins associated with invasion and infection of the mammalian host.Conquering 'snail fever': schistosomiasis and its control in China.Acetate and succinate production in amoebae, helminths, diplomonads, trichomonads and trypanosomatids: common and diverse metabolic strategies used by parasitic lower eukaryotes.Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages.Advances in the discovery and development of trematocidal drugs.Vaccines and diagnostics for zoonotic schistosomiasis japonica.Fasciola hepatica - the pilot study of in vitro assessing immune response against native and recombinant antigens of the fluke.Efficacy and safety of artemether against a natural Fasciola hepatica infection in sheep.A model to assess the efficacy of vaccines for control of liver fluke infection.Immunization with crude antigens plus aluminium hydroxide protects cattle from Fasciola hepatica infection.Human fascioliasis by Fasciola hepatica: the first case report in Nepal.
P2860
Q24650873-8A9B3A6B-0B4A-4C1D-B694-C6C8AAE658ADQ24657733-329E7F00-9976-434C-9000-752DDBA11185Q27649433-88F307A1-5880-445F-A954-87CB0905BCE3Q28474406-E78123ED-DA13-4061-8417-EDB9A4384DD8Q28476800-0E548747-072D-466D-8D19-C1663A131E05Q28541967-7FF01CD3-566D-444F-8365-87ECB42EAD42Q28743949-5A859132-1B66-4CEE-BC5B-8B172A3584AEQ31080479-AB424418-8CD5-4EA6-85AF-CDD3DADC7B5BQ33371412-81CF4B49-5DDB-42FC-BCA1-82612EA85DDDQ33403178-346A0909-61D2-448D-A50F-B8403962FEE4Q33420810-8479DACF-6E55-47DE-9CD8-A39CB860DA8AQ33466804-53ABDDFB-BFDF-4E8B-A568-95D44DF3AF98Q33563376-4AC8213C-3FF3-4538-92F5-598A0F6ADB83Q33613852-BA897887-8DAE-478D-B0AC-B1D9409A5D74Q33825627-466EA389-0B38-4A58-A8F2-2F2B52869531Q33877592-AC823747-A8BE-4E3D-9E63-D7944F531231Q34290075-01BDB182-A44B-49B8-9B86-25C212161F21Q34595664-4A3A9AB1-AF3D-464C-934D-8B5D2021B0BDQ35329011-20B20351-1FE0-465E-BFF1-4E803E074394Q35996950-784F5418-F759-481A-8A3F-F551803935B3Q36257836-EA203E57-AF20-4439-9896-D530D6E69688Q36319768-D01C079F-894A-4354-99E5-FBCED4A29DFDQ36386873-4D16D219-BE20-4BC4-8A74-2B306BE03A1DQ36750810-7C15DA36-A160-4071-B22F-64CF36FCD890Q36928786-B85232FA-4586-4AA1-9F84-9C5A56160744Q36936145-003E4A96-84EF-4C4F-BBDD-9E4BB0E2ECFCQ37092377-EBE67F9E-5C53-4DD3-B4D5-6E5CF16651BDQ37196249-9C243A3E-8B72-4F93-BB69-B054F748BA37Q37239407-48EDFBA4-E5F6-412A-932D-8D0DA7E0DE78Q37294418-A84171D1-B65D-4B9B-9DAD-81530E40D246Q37463234-BAFCEA94-DC64-4D63-8DCE-C7E202ED70A5Q37661156-2B8AE2BD-69A5-4C29-8106-9E9C4CBAE3D0Q37693527-2909C4BF-85FA-400D-9E7E-2970694B8127Q38089167-17CB581E-87D5-4EAA-8FB1-56C33F5AA97AQ38264085-406FD2B9-4470-404F-9E4D-004AD41DE705Q39043252-945068B0-0972-41BF-A301-E49077444FABQ39126668-E57F7BA6-2C37-407E-A55E-657961A5CE28Q39450217-B76DC6DC-88FC-470F-B08D-9022701C60CDQ39776567-94722CC0-97FB-45BD-89FC-4140AA2C0CD1Q40040748-4554EF3B-7DA9-4538-8431-A39A55706FD7
P2860
Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Vaccines against the zoonotic ...... patica and Fasciola gigantica.
@ast
Vaccines against the zoonotic ...... patica and Fasciola gigantica.
@en
type
label
Vaccines against the zoonotic ...... patica and Fasciola gigantica.
@ast
Vaccines against the zoonotic ...... patica and Fasciola gigantica.
@en
prefLabel
Vaccines against the zoonotic ...... patica and Fasciola gigantica.
@ast
Vaccines against the zoonotic ...... patica and Fasciola gigantica.
@en
P2860
P1433
P1476
Vaccines against the zoonotic ...... patica and Fasciola gigantica.
@en
P2093
P2860
P304
P356
10.1017/S0031182006001806
P478
P577
2006-01-01T00:00:00Z